Post-INFECT: Investigating Neuroinflammation and its eFEcts in post-COVID syndrome: an imaging sTudy

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-522349-23-00

Enrollment

Registered

2026-06-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-COVID syndrome

Brief summary

Cellular metabolism in the brain as measured with dynamic [18F]FDG PET, Structural and functional parameters of the brain as measured with MRI, Immune-related blood parameters

Detailed description

Presence and severity of symptoms as measured with questionnaires

Interventions

DRUGFludeoxyglucose (18F)-Curium

DRUG185 MBq/ml oplossing voor injectie.

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Cellular metabolism in the brain as measured with dynamic [18F]FDG PET, Structural and functional parameters of the brain as measured with MRI, Immune-related blood parameters	—

Secondary

Measure	Time frame
Presence and severity of symptoms as measured with questionnaires	—

Outcome results

None listed

Source: EU CTIS · Data processed: Jun 2, 2026